Ravelli, GP, Stein, ZA, Susser, MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 1976; 295, 349–353.
Barker, DJ, Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986; 1, 1077–1081.
Barker, DJ, Winter, PD, Osmond, C, Margetts, B, Simmonds, SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989; 2, 577–580.
Barker, DJ. Deprivation in infancy and risk of ischaemic heart disease. Lancet. 1991; 337, 981.
Barker, DJ, Gluckman, PD, Godfrey, KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993; 341, 938–941.
McLachlan, JA, Newbold, RR, Bullock, BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res. 1980; 40, 3988–3999.
Newbold, RR, Bullock, BC, McLachlan, JA. Progressive proliferative changes in the oviduct of mice following developmental exposure to diethylstilbestrol. Teratog Carcinog Mutagen. 1985; 5, 473–480.
Burbacher, TM, Rodier, PM, Weiss, B. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol. 1990; 12, 191–202.
Gilbert, SG, Grant-Webster, KS. Neurobehavioral effects of developmental methylmercury exposure. Environ Health Perspect. 1995; 103(Suppl. 6), 135–142.
Bellinger, D, Sloman, J, Leviton, A, et al. Low-level lead exposure and children’s cognitive function in the preschool years. Pediatrics. 1991; 87, 219–227.
Bellinger, D, Dietrich, KN. Low-level lead exposure and cognitive function in children. Pediatr Ann. 1994; 23, 600–605.
Banks, EC, Ferretti, LE, Shucard, DW. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology. 1997; 18, 237–281.
Needleman, HL, Schell, A, Bellinger, D, Leviton, A, Allred, EN. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990; 322, 83–88.
Venter, JC, Adams, MD, Myers, EW, et al. The sequence of the human genome. Science. 2001; 291, 1304–1351.
Wadhwa, PD, Buss, C, Entringer, S, Swanson, JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009; 27, 358–368.
Callinan, PA, Feinberg, AP. The emerging science of epigenomics. Hum Mol Genet. 2006; 15(Spec No. 1), R95–R101.
Huang, WW, Yin, Y, Bi, Q, et al. Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol Endocrinol. 2005; 19, 669–682.
Lehmann, KP, Phillips, S, Sar, M, Foster, PM, Gaido, KW. Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicol Sci. 2004; 81, 60–68.
Ruden, DM, Xiao, L, Garfinkel, MD, Lu, X. Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer. Hum Mol Genet. 2005; 14(Spec No. 1), R149–R155.
Bhattacherjee, V, Mukhopadhyay, P, Singh, S, et al. Neural crest and mesoderm lineage-dependent gene expression in orofacial development. Differentiation. 2007; 75, 463–477.
Dolinoy, DC, Weidman, JR, Jirtle, RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol. 2007; 23, 297–307.
Dolinoy, DC, Huang, D, Jirtle, RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A. 2007; 104, 13056–13061.
Grun, F, Blumberg, B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology. 2006; 147(Suppl.), S50–S55.
Keri, RA, Ho, SM, Hunt, PA, et al. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol. 2007; 24, 240–252.
Schug, TT, Janesick, A, Blumberg, B, Heindel, JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol. 2011; 127, 204–215.
Soto, AM, Maffini, MV, Sonnenschein, C. Neoplasia as development gone awry: the role of endocrine disruptors. Int J Androl. 2008; 31, 288–293.
Janesick, A, Blumberg, B. Obesogens, stem cells and the developmental programming of obesity. Int J Androl. 2012; 35, 437–448.
Heindel, JJ, McAllister, KA, Worth, L Jr, Tyson, FL. Environmental epigenomics, imprinting and disease susceptibility. Epigenetics. 2006; 1, 1–6.
Kang, ER, Iqbal, K, Tran, DA, et al. Effects of endocrine disruptors on imprinted gene expression in the mouse embryo. Epigenetics. 2011; 6, 937–950.
Grandjean, P, Weihe, P. Developmental origins of environmentally induced disease and dysfunction International Conference on Foetal Programming and Developmental Toxicity, Torshavn, Faroe Islands, 20–24 May, 2007. Basic Clin Pharmacol Toxicol. 2008; 102, 71–72.
Darney, S, Fowler, B, Grandjean, P, et al. Prenatal Programming and Toxicity II (PPTOX II): role of environmental stressors in the developmental origins of disease. Reprod Toxicol. 2011; 31, 271.
Schug, TT, Barouki, R, Gluckman, P, et al. PPTOX III: environmental stressors in the developmental origins of disease: evidence and mechanisms. Toxicol Sci. 2013; 131, 343–350.
Barouki, R, Gluckman, PD, Grandjean, P, Hanson, M, Heindel, JJ. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012; 11, 42 (http://www.ehjournal.net/content/11/1/42).
Needleman, HL, McFarland, C, Ness, RB, Fienberg, SE, Tobin, MJ. Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol. 2002; 24, 711–717.
Needleman, HL, Riess, JA, Tobin, MJ, Biesecker, GE, Greenhouse, JB. Bone lead levels and delinquent behavior. JAMA. 1996; 275, 363–369.
Dietrich, KN, Succop, PA, Berger, OG, Hammond, PB, Bornschein, RL. Lead exposure and the cognitive development of urban preschool children: the Cincinnati Lead Study cohort at age 4 years. Neurotoxicol Teratol. 1991; 13, 203–211.
Lanphear, BP, Hornung, R, Khoury, J, et al. Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect. 2005; 113, 894–899.
Pounds, JG, Long, GJ, Rosen, JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect. 1991; 91, 17–32.
Rice, DC, Evangelista de Duffard, AM, Duffard, R, et al. Lessons for neurotoxicology from selected model compounds: SGOMSEC joint report. Environ Health Perspect. 1996; 104(Suppl. 2), 205–215.
Torres-Sanchez, LE, Berkowitz, G, Lopez-Carrillo, L, et al. Intrauterine lead exposure and preterm birth. Environ Res. 1999; 81, 297–301.
Haynes, EN, Chen, A, Ryan, P, et al. Exposure to airborne metals and particulate matter and risk for youth adjudicated for criminal activity. Environ Res. 2011; 111, 1243–1248.
Grandjean, P, White, RF. Neurobehavioral dysfunction as a possible sentinel of methylmercury exposure. Hum Ecol Risk Assess. 2001; 7, 1079–1089.
Grandjean, P, Weihe, P, Needham, LL, et al. Relation of a seafood diet to mercury, selenium, arsenic, and polychlorinated biphenyl and other organochlorine concentrations in human milk. Environ Res. 1995; 71, 29–38.
Dalgard, C, Grandjean, P, Jorgensen, PJ, Weihe, P. Mercury in the umbilical cord: implications for risk assessment for minamata disease. Environ Health Perspect. 1994; 102, 548–550.
Grandjean, P, Weihe, P. Neurobehavioral effects of intrauterine mercury exposure: potential sources of bias. Environ Res. 1993; 61, 176–183.
Grandjean, P, Weihe, P, Jorgensen, PJ, et al. Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch Environ Health. 1992; 47, 185–195.
Grandjean, P, Weihe, P, White, RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997; 19, 417–428.
Rice, DC. The US EPA reference dose for methylmercury: sources of uncertainty. Environ Res. 2004; 95, 406–413.
Murata, K, Budtz-Jorgensen, E, Grandjean, P. Benchmark dose calculations for methylmercury-associated delays on evoked potential latencies in two cohorts of children. Risk Anal. 2002; 22, 465–474.
Budtz-Jorgensen, E, Grandjean, P, Keiding, N, White, RF, Weihe, P. Benchmark dose calculations of methylmercury-associated neurobehavioural deficits. Toxicol Lett. 2000; 112–113, 193–199.
Budtz-Jorgensen, E, Grandjean, P, Weihe, P. Separation of risks and benefits of seafood intake. Environ Health Perspect. 2007; 115, 323–327.
McGivern, RF, Sokol, RZ, Berman, NG. Prenatal lead exposure in the rat during the third week of gestation: long-term behavioral, physiological, and anatomical effects associated with reproduction. Toxicol Appl Pharmacol. 1991; 110, 206–215.
Crews, D, Gore, AC, Hsu, TS, et al. Transgenerational epigenetic imprints on mate preference. Proc Natl Acad Sci U S A. 2007; 104, 5942–5946.
Anway, MD, Rekow, SS, Skinner, MK. Transgenerational epigenetic programming of the embryonic testis transcriptome. Genomics. 2008; 91, 30–40.
Guerrero-Bosagna, C, Settles, M, Lucker, B, Skinner, MK. Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome. PLoS One. 2010; 5, e13100.
Skinner, MK, Manikkam, M, Guerrero-Bosagna, C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 2010; 21, 214–222.
Anway, MD, Cupp, AS, Uzumcu, M, Skinner, MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005; 308, 1466–1469.
Birnbaum, LS. NIEHS’s new strategic plan. Environ Health Perspect. 2012; 120, a298.
Rutter, M, Jones, RR (eds). Lead versus health: sources and effects of low level lead exposure. Arch Dis Child. 1983; 58, 759.
Skinner, MK, Anway, MD, Savenkova, MI, Gore, AC, Crews, D. Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One. 2008; 3, e3745.
Skinner, MK, Manikkam, M, Guerrero-Bosagna, C. Epigenetic transgenerational actions of endocrine disruptors. Reprod Toxicol. 2011; 31, 337–343.
Wolstenholme, JT, Edwards, M, Shetty, SR, et al. Gestational exposure to bisphenol a produces transgenerational changes in behaviors and gene expression. Endocrinology. 2012; 153, 3828–3838.
Wolstenholme, JT, Taylor, JA, Shetty, SR, et al. Gestational exposure to low dose bisphenol A alters social behavior in juvenile mice. PLoS One. 2011; 6, e25448.
Wolstenholme, JT, Rissman, EF, Connelly, JJ. The role of bisphenol A in shaping the brain, epigenome and behavior. Horm Behav. 2011; 59, 296–305.